The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 study of the OX40 agonist, BGB-A445, with or without tislelizumab, an anti-PD-1 monoclonal antibody, in patients with advanced solid tumors.
 
Jayesh Desai
Consulting or Advisory Role - Amgen (Inst); Bayer; BeiGene; Boehringer Ingelheim; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Merck KGaA; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Roche (Inst)
 
Diwakar Davar
Honoraria - ACM Biolabs; Clinical Care Options (CCO); Gerson Lehrman Group; Medical Learning Group; Merck; Xilio Therapeutics
Consulting or Advisory Role - Checkmate Pharmaceuticals; Clinical Care Options; Finch Therapeutics; Gerson Lehrman Group; Xilio Therapeutics
Speakers' Bureau - Castle Biosciences
Research Funding - Arcus Biosciences; CellSight Technologies; Checkmate Pharmaceuticals; GlaxoSmithKline; Merck; Merck; Zucero Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Application No.: 63/124,231; Enteric Microbiotype Signatures of Immune-related Adverse Events and Response in Relation to Anti-PD-1 Immunotherapy
 
Sanjeev Deva
No Relationships to Disclose
 
Bo Gao
Consulting or Advisory Role - BeiGene; IMPAC Medical Systems; IMPAC Medical Systems; MSD
 
Tianshu Liu
No Relationships to Disclose
 
Marco Matos
No Relationships to Disclose
 
Tarek Meniawy
Consulting or Advisory Role - BMS GmbH & Co. KG; Eisai; GlaxoSmithKline; MSD; Novartis; Regeneron; Sanofi
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck Serono (Inst); Regeneron (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - BMS GmbH & Co. KG
 
Kenneth John O'Byrne
Stock and Other Ownership Interests - Carpe Vitae Pharmaceuticals; DGC diagnostics; RepLuca Pharmaceuticals
Honoraria - Amgen; Astrazeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Takeda; TriStar Technology Group; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi; Yuhan
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen-Cilag; Merck; Merck Sharp & Dohme; Pfizer; Roche
Patents, Royalties, Other Intellectual Property - I am named on 4 active patents, 2 published and 2 provisional (Inst)
 
Meili Sun
No Relationships to Disclose
 
Mark Voskoboynik
Honoraria - MSD
Consulting or Advisory Role - AstraZeneca; MSD
Research Funding - Alpine Immune Sciences (Inst); Antengene (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Atridia (Inst); BeiGene (Inst); Hengrui Pharmaceutical (Inst); Hinova Pharmaceuticals (Inst); MSD (Inst); Virocure (Inst)
 
Kunyu Yang
No Relationships to Disclose
 
Xinmin Yu
Research Funding - BeiGene; BMS; Hansoh; Innovent Biologics; MSD
 
Xin Chen
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Research Funding - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
 
Yan Dong
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
 
Hugh Giovinazzo
Employment - BeiGene; Theravance
Stock and Other Ownership Interests - BeiGene; Theravance
 
Shiangjiin Leaw
No Relationships to Disclose
 
Deepa Patel
No Relationships to Disclose
 
Tahmina Rahman
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Yanjie Wu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Daphne Day
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); EpimAb Biotherapeutics (Inst); Harbour BioMed (Inst); Maxinovel (Inst); MSD (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); PharmAbcine (Inst); Roche (Inst)